Cutler Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	–	–	3674
2022 Q4	–	Hold	0	–	–	–	4285
2022 Q3	–	Sell	-800	Closed	-$13K	–	4828
2022 Q2	$11K	Sell	800 -4,646	-85%	-$86.7K	﹤0.01%	3098
2022 Q1	$131K	Sell	5,446 -29,459	-84%	-$713K	0.01%	1501
2021 Q4	$814K	Buy	34,905 +27,405	+365%	+$551K	0.06%	536
2021 Q3	$124K	Buy	7,500 +7,400	+7,400%	+$143K	0.01%	1739
2021 Q2	$2K	Hold	100	–	–	﹤0.01%	4920
2021 Q1	$2K	Buy	+100	New	+$4.4K	﹤0.01%	4845
2020 Q4	–	Hold	0	–	–	–	4718
2020 Q3	–	Hold	0	–	–	–	4589
2020 Q2	–	Hold	0	–	–	–	4284
2020 Q1	–	Sell	-4,100	Closed	-$169K	–	3926
2019 Q4	$175K	Buy	4,100 +827	+25%	+$36K	0.01%	892
2019 Q3	$117K	Buy	+3,273	New	+$99.2K	0.01%	990
2019 Q2	–	Sell	-6,878	Closed	-$176K	–	4135
2019 Q1	$184K	Buy	6,878 +4,011	+140%	+$93.7K	0.02%	679
2018 Q4	$46K	Buy	+2,867	New	+$55.7K	0.01%	1518
2018 Q3	–	Sell	-2,541	Closed	-$40K	–	4016
2018 Q2	$38K	Sell	2,541 -30,195	-92%	-$538K	﹤0.01%	1775
2018 Q1	$735K	Buy	32,736 +18,365	+128%	+$508K	0.08%	299
2017 Q4	$432K	Sell	14,371 -2,773	-16%	-$88.7K	0.02%	608
2017 Q3	$645K	Sell	17,144 -12,290	-42%	-$400K	0.03%	524
2017 Q2	$820K	Sell	29,434 -17,739	-38%	-$529K	0.04%	475
2017 Q1	$1.62M	Buy	47,173 +35,976	+321%	+$1.27M	0.08%	244
2016 Q4	$322K	Sell	11,197 -13,653	-55%	-$361K	0.02%	970
2016 Q3	$790K	Buy	24,850 +8,908	+56%	+$302K	0.05%	414
2016 Q2	$517K	Buy	15,942 +11,933	+298%	+$399K	0.04%	573
2016 Q1	$112K	Sell	4,009 -40,379	-91%	-$880K	0.01%	1506
2015 Q4	$1.58M	Buy	+44,388	New	+$1.56M	0.13%	216